Key Findings
- Analysis of 15,456 colorectal cancers profiled by Caris confirmed that elevated expression of SNHG11, a long non-coding RNA, was associated with CMS2 biology, longer overall survival, and longer time on anti-EGFR therapy, supporting SNHG11 as a potential prognostic and predictive biomarker in colorectal cancer.
- This study highlights how comprehensive molecular profiling can uncover clinically relevant molecular subgroups, prognostic biomarkers, and therapeutic targets across diverse tumor types, supporting more precise biomarkerdriven research and treatment strategies.